Rang	Name	Position
1	Mr. Kevin Hykes	President, CEO & Director
2	Dr. Philip B. Adamson M.D., M.Sc.	Chief Medical Officer
3	Mr. Jared Oasheim	Chief Financial Officer
4	Mr. Brent Binkowski	Chief Operating Officer
5	Mr. Matt Klein	Vice President, Legal & Compliance Officer
6	Mr. Paul Verrastro	Interim Head of Sales
7	Mr. Patrick Lyon	Vice President of Marketing
8	Mr. Gregory Morrison	Chief Human Resources Officer
9	Ms. Bonnie Handke M.B.A., R.N.	Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Johnson & Johnson	15,11%	12,36 Mio. USD
2	NEA Management Company, LLC	7,61%	6,22 Mio. USD
3	BlackRock Inc	3,85%	3,15 Mio. USD
4	GSK PLC	3,78%	3,09 Mio. USD
5	Vanguard Capital Management, LLC	3,42%	2,80 Mio. USD
6	Royal Bank of Canada	2,65%	2,17 Mio. USD
7	Balyasny Asset Management LLC	2,37%	1,94 Mio. USD
8	Silvercrest Asset Management Group LLC	2,15%	1,76 Mio. USD
9	Geode Capital Management, LLC	1,60%	1,31 Mio. USD
10	Partner Fund Management LP	1,39%	1,14 Mio. USD
11	State Street Corp	1,32%	1,08 Mio. USD
12	The Goldman Sachs Group Inc	0,75%	0,62 Mio. USD
13	Tudor Investment Corp Et AL	0,74%	0,61 Mio. USD
14	Northern Trust Corp	0,56%	0,46 Mio. USD
15	Morgan Stanley - Brokerage Accounts	0,52%	0,43 Mio. USD
16	Kestra Advisory Services, LLC	0,50%	0,41 Mio. USD
17	Dimensional Fund Advisors, Inc.	0,48%	0,39 Mio. USD
18	Vanguard Fiduciary Trust Co	0,48%	0,39 Mio. USD
19	Quantinno Capital Management LP	0,43%	0,36 Mio. USD
20	Two Sigma Investments LLC	0,43%	0,35 Mio. USD